The synthesis and structure-activity studies of a series of 
6-substituted-4-anilino-[1,7]-naphthyridine-3-carbonitriles as inhibitors of 
Tpl2 kinase are described. The early exploratory work described here may lead to 
the discovery of compounds with significant therapeutic potential for treating 
rheumatoid arthritis and other inflammatory diseases.